Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
01 Jul 2024
Historique:
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: epublish

Résumé

There are limited data about determinant factors of target lesion failure (TLF) in lesions after percutaneous coronary intervention (PCI) using a drug-coated balloon (DCB) for de novo coronary artery lesions, including optical coherence tomography (OCT) findings. The present study aims to investigate the associated factors of TLF in de novo coronary artery lesions with DCB treatment. We retrospectively enrolled 328 de novo coronary artery lesions in 328 patients who had undergone PCI with a DCB. All lesions had been treated without a stent, and both pre- and post-PCI OCT had been carried out. Patients were divided into two groups, with or without TLF, which was defined as a composite of culprit lesion-related cardiac death, myocardial infarction, and target lesion revascularisation, and the associated factors of TLF were assessed. At the median follow-up period of 460 days, TLF events occurred in 31 patients (9.5%) and were associated with patients requiring haemodialysis (HD; 29.0% vs 10.8%), with a severely calcified lesion (median maximum calcium arc 215° vs 104°), and with the absence of OCT medial dissection (16.1% vs 60.9%) as opposed to those without TLF events. In Cox multivariable logistic regression analysis, HD (hazard ratio [HR]: 2.26, 95% confidence interval [CI]: 1.00-5.11; p=0.049), maximum calcium arc (per 90°, HR: 1.34, 95% CI: 1.05-1.72; p=0.02), and the absence of post-PCI medial dissection on OCT (HR: 8.24, 95% CI: 3.15-21.6; p<0.001) were independently associated with TLF. In de novo coronary artery lesions that received DCB treatment, factors associated with TLF were being on HD, the presence of a severely calcified lesion, and the absence of post-PCI medial dissection.

Sections du résumé

BACKGROUND BACKGROUND
There are limited data about determinant factors of target lesion failure (TLF) in lesions after percutaneous coronary intervention (PCI) using a drug-coated balloon (DCB) for de novo coronary artery lesions, including optical coherence tomography (OCT) findings.
AIMS OBJECTIVE
The present study aims to investigate the associated factors of TLF in de novo coronary artery lesions with DCB treatment.
METHODS METHODS
We retrospectively enrolled 328 de novo coronary artery lesions in 328 patients who had undergone PCI with a DCB. All lesions had been treated without a stent, and both pre- and post-PCI OCT had been carried out. Patients were divided into two groups, with or without TLF, which was defined as a composite of culprit lesion-related cardiac death, myocardial infarction, and target lesion revascularisation, and the associated factors of TLF were assessed.
RESULTS RESULTS
At the median follow-up period of 460 days, TLF events occurred in 31 patients (9.5%) and were associated with patients requiring haemodialysis (HD; 29.0% vs 10.8%), with a severely calcified lesion (median maximum calcium arc 215° vs 104°), and with the absence of OCT medial dissection (16.1% vs 60.9%) as opposed to those without TLF events. In Cox multivariable logistic regression analysis, HD (hazard ratio [HR]: 2.26, 95% confidence interval [CI]: 1.00-5.11; p=0.049), maximum calcium arc (per 90°, HR: 1.34, 95% CI: 1.05-1.72; p=0.02), and the absence of post-PCI medial dissection on OCT (HR: 8.24, 95% CI: 3.15-21.6; p<0.001) were independently associated with TLF.
CONCLUSIONS CONCLUSIONS
In de novo coronary artery lesions that received DCB treatment, factors associated with TLF were being on HD, the presence of a severely calcified lesion, and the absence of post-PCI medial dissection.

Identifiants

pubmed: 38949242
pii: EIJ-D-23-01006
doi: 10.4244/EIJ-D-23-01006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e818-e825

Auteurs

Tetsumin Lee (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Takashi Ashikaga (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Toshihiro Nozato (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Yasutoshi Nagata (Y)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Masakazu Kaneko (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Ryoichi Miyazaki (R)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Toru Misawa (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Yuta Taomoto (Y)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Shinichiro Okata (S)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Masashi Nagase (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Tomoki Horie (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Mao Terui (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Daigo Kachi (D)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Yuki Odanaka (Y)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Kazuki Matsuda (K)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Michihito Naito (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Ayaka Koido (A)

Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH